The number of youth receiving medicine for emotional and mental health in Aotearoa New Zealand has increased relative to previous years. Perhaps even more concerning, is the widening of the gap in prescribing to rangatahi Māori and young Pacific peoples compared to their peers of European/Other ethnicity.
Find out more in this press release.
Our June newsletter features our youth mental health reflection activity and our upcoming webinar with Drs Cathy Stephenson and Arran Culver. It also highlights our free EPiC training sessions and resources about immune checkpoint inhibitors, triazolam, and ADHD medicine changes.
Data reviewed by He Ako Hiringa suggest that 70,000 patients were still being dispensed cilazapril as at the end of May 2023. This ACE inhibitor is set to be delisted by the end of the year. Consider changing patients to another medicine now, to ensure a smooth pre-Christmas transition.
Find out more in this press release.
Our May newsletter introduces our CQI Toolkit and Virus Action Plans, two new resources focusing on antimicrobial stewardship. It also highlights the recent changes to phenobarbitone branding and liraglutide funding.
Our April newsletter highlights our new UTI case study and microlearning piece on youth mental health. It also outlines the resources that you can expect to see from us soon.
Our March newsletter highlights our new liraglutide algorithm, the recording of our cultural safety webinar, and our latest antimicrobial content.
Our February newsletter features resources about antibiotics for uncomplicated UTI, Māori experiences of care for minor ailments, and ACE inhibitor changes.
Our January newsletter outlines what you can expect from us this year. This includes two podcasts on antimicrobial stewardship, an equity webinar, a 'viral prescription' form, and a quality improvement planning template.
It's been a huge year for us, and we've been so grateful for your support. In our December newsletter we revisit our most popular resources from the year, outline what you can expect from us in 2023, and provide you with updates from our sector relationship manager.
Our November newsletter focuses on the launch of our antimicrobial content including an article on antimicrobial resistance and the new EPiC Antibiotics dashboard.
This page provides the specific methodology used for each data story featured in EPiC Antibiotics.
Our October newsletter features EPiC updates and training, Evusheld, new brand changes and more.